Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × FOLFOXIRI protocol × 1 year × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Neuroendocrine 1

Interventions

Specimen Handling 428 pembrolizumab 422 Magnetic Resonance Spectroscopy 370 Carboplatin 302 Cyclophosphamide 270 Cisplatin 255 Biopsy 237 Radiotherapy 213 Paclitaxel 199 Gemcitabine 199 Bevacizumab 186 Nivolumab 170 venetoclax 166 fludarabine 156 Drug Therapy 145 Blood Specimen Collection 144 Dexamethasone 140 Docetaxel 135 Oxaliplatin 134 Injections 134 Capecitabine 133 Fluorouracil 132 Radiosurgery 122 Rituximab 121 Standard of Care 119 Pemetrexed 114 atezolizumab 105 durvalumab 100 Radiation 100 Doxorubicin 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04325425 2025-09-30

FOLFIRINEC

Centre Hospitalier Universitaire Dijon

Phase 2 Recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡